PRB4 and rhabdomyosarcoma: PO was also shown to inhibit cell viability in several cancer cell lines, including two PDAC cell lines and was recently reported to inhibit TBX3, and its homologue TBX2, and to exert anti‐cancer activity in TBX2‐/3‐dependent melanoma and rhabdomyosarcoma [16].